Company overview
Middle East and North Africa - MENA - Diagnostics is leading distributor of diagnostic and medical products in Libya. We represent leading instrument companies in the diagnostic and biotechnology fields, and several suppliers of kits, reagents and consumables. Through MENA Pharma we also distribute medical equipment, drugs and healthcare products. We offer our customers excellent service, support, and through MENA Education we offer training of their staff either on-site in Libya or at our facilities in Sweden.

Our vision
MENA Diagnostics shall be the leading distributor of diagnostic and medical products to the Libyan healthcare sector, and optimum partner to any foreign company in the diagnostic and medical fields that plans to introduce their products on the rapidly growing Libyan market.

Company history
MENA Diagnostics was founded in 1996 in Sweden by Dr Abdalla Elbergli and Professor Mikael Kubista as one of four sister companies in the Xanadu group. The others are LightUp Technologies AB, TATAA Biocenter AB, and MultiD Analyses AB. In 1999, when United Nations withdraw their sanctions against Libya, Mikael Kubista was appointed international scientific advisor to Unesco to help establishing biotechnology research and modern diagnostics in Libya. MENA Diagnostics became one of the main suppliers of diagnostic products and research instruments to Libya, many of which where installed personally by Mikael. In 2003 MENA Diagnostics main office was moved to Tripoli, and in 2004/2005, when drug import to Libya was deregulated, MENA Pharma division was established. Today MENA Diagnostics has offices in Tripoli, Bengazi, Musrata and Gothenburg (Sweden). We have three warehouses and general store facilities including freezers. We have internationally highly experienced management, a strong and dedicated sales and service team of five people with medical background, a store manager and a company accountant.

Management
PhD Abdalla Elbergli, president. Dr Elbergali co-founded MENA Diagnostics when working with Professor Mikael Kubista as postdoctor fellow at Chalmers University and Sahlgrenska University hospital during 1994-1999. By training Dr Elbergali is biostatistician with PhD from Bristol University, UK. He is experienced manager and company leader.

Professor Mikael Kubista, president of Swedish office. Dr Kubista has PhD in chemistry from Chalmers University, and postdoctoral experience from Yale University, US. Professor Kubista co-founded MENA diagnostics with Dr Elbergali, and he has previously founded the diagnostic company LightUp Technologies AB, the diagnostic service provider TATAA Biocenter, and the bioinformatics company MultiD Analyses AB. Dr Kubista has developed several technologies and solutions that are on the diagnostic market today, and he serves as scientific advisor to several international biotech and Pharma companies.

Advisors
PhD Fateh Elnefrew, advisor to MENA Diagnostics. Fateh has PhD in molecular biology from Manchester University. He was running the diagnostic laboratory at Subrata cancer hospital for many years, and he is presently laboratory manager of the St James hospital diagnostic center in Tripoli, Libya.